Trial of New Antiviral Drugs in Patients With Decompensated Liver Cirrhosis Due to HCV Infection
Christina Alphonse Anwar;
Abstract
Egypt has the largest burden of Hepatitis C virus in the world, the overall prevalence for positive HCV Ab in Egypt was 14.7%. 9.8% of the population continues to have HCV RNA, which means that 7.8 millions of the Egyptians continue to have chronic active
Other data
| Title | Trial of New Antiviral Drugs in Patients With Decompensated Liver Cirrhosis Due to HCV Infection | Other Titles | تجربة مضادات الفيروسات علي مرضى تليف الكبد الذين يعانون من فشل بوظائف الكبد نتيجة للاصابة المزمنة بالفيروس الكبدى سى | Authors | Christina Alphonse Anwar | Keywords | Trial of New Antiviral Drugs in Patients With Decompensated Liver Cirrhosis Due to HCV Infection | Issue Date | 2011 | Description | Egypt has the largest burden of Hepatitis C virus in the world, the overall prevalence for positive HCV Ab in Egypt was 14.7%. 9.8% of the population continues to have HCV RNA, which means that 7.8 millions of the Egyptians continue to have chronic active |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 106978p4349.pdf | 2.01 MB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.